Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04526704
Title Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With Pexidartinib (PLX3397)
Recruitment Active, not recruiting
Gender both
Phase FDA approved
Variant Requirements No
Sponsors Daiichi Sankyo, Inc.

tenosynovial giant cell tumor



Age Groups: adult | senior
Covered Countries USA | ITA | ESP

No variant requirements are available.